Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial

Published:2006-03-07 Issue:4 Volume:58 Page:555-560
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Stathopoulos G. P.,Katis C.,Tsavdaridis D.,Dimitroulis J.,Karaindros D.,Stathopoulos J.,Dimou E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-006-0204-y.pdf

Reference32 articles.

1. Fosella FV, de Vore R, Kerr RN et al (2000) Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. J Clin Oncol 18:2354–2362

2. Georgoulias V, Kouroussis CH Androulakis N et al (1999) Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial. J Clin Oncol 17:914–920

3. Stathopoulos GP, Veslemes M, Georgatou N et al (2004) Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial. Ann Oncol 15:1048–1055

4. Crino L, Scagliotti G, Maragolo M et al (1997) Cisplatin–gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. J Clin Oncol 15:297–303

5. Huizing MT, Giaccone G, van Warmerdam LJC et al (1997) Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. J Clin Oncol 15:317–329

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria of T Lymphocytes Promote Anti-Pulmonary Tumor Immune Response;World Journal of Oncology;2024-06

2. Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line;Frontiers in Cell and Developmental Biology;2020-12-23

3. Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study;Anti-Cancer Drugs;2010-02

4. The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies;Journal of Bioenergetics and Biomembranes;2007-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3